SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+1.95%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.65B
AUM Growth
+$1.65B
(+3.8%)
Cap. Flow
+$95.2M
Cap. Flow
% of AUM
5.78%
Top 10 Holdings %
Top 10 Hldgs %
61.91%
Holding
77
New
11
Increased
17
Reduced
15
Closed
10
Top Buys
| 1 |
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
|
$85.8M |
| 2 |
Vera Therapeutics
VERA
|
$38.7M |
| 3 |
Biogen
BIIB
|
$38.3M |
| 4 |
Sarepta Therapeutics
SRPT
|
$23.2M |
| 5 |
Heron Therapeutics
HRTX
|
$22.8M |
Top Sells
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$42.1M |
| 2 |
Eli Lilly
LLY
|
$33.7M |
| 3 |
Merus
MRUS
|
$27.4M |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$22.5M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$14M |
Sector Composition
| 1 | Healthcare | 98.84% |